The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: A phase I/II trial of novel MDM2 inhibitor alrizomadlin (APG-115), with or without platinum chemotherapy, in patients with p53 wild-type salivary gland carcinoma.
 
Paul Swiecicki
Consulting or Advisory Role - Prelude Therapeutics; Regeneron
Research Funding - Ascentage Pharma Group; Pfizer
 
Yuefen Tang
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Alexander T. Pearson
Stock and Other Ownership Interests - Inovalon (I)
Consulting or Advisory Role - Prelude Therapeutics
 
Jameel Muzaffar
No Relationships to Disclose
 
Mary J. Fidler
Honoraria - AstraZeneca; Genentech; Merck
Consulting or Advisory Role - Abbvie (I); AstraZeneca; G1 Therapeutics; Genentech (I); Rakuten Medical (Inst)
Speakers' Bureau - Genentech; Merck
Research Funding - AstraZeneca (Inst); Biodesix; CytomX Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer/EMD Serono; Rakuten Medical (Inst)
 
Robert Winkler
Employment - Ascentage Pharma
 
Tommy Fu
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Mingyu Li
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Mohammad Ahmad
Employment - Ascentage Pharma
 
Dajun Yang
Employment - Ascentage Pharma; Ascentage Pharma (I); HealthQuest Pharma; HealthQuest Pharma (I)
Leadership - Ascentage Pharma; Ascentage Pharma (I); HealthQuest Pharma; HealthQuest Pharma (I)
Stock and Other Ownership Interests - Ascentage Pharma; Ascentage Pharma (I)
Research Funding - Sun Yat-sen University; Sun Yat-sen University (Inst)
Patents, Royalties, Other Intellectual Property - Ascentage Pharma; Ascentage Pharma (I)
Travel, Accommodations, Expenses - Ascentage Pharma; Ascentage Pharma (I); HealthQuest Pharma; HealthQuest Pharma (I)
 
Yifan Zhai
Employment - Ascentage Pharma
Leadership - Ascentage Pharma; Ascentage Pharma (I)
Stock and Other Ownership Interests - Ascentage Pharma; Ascentage Pharma (I)
Research Funding - Ascentage Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Ascentage Pharma; Ascentage Pharma (I); Ascentage Pharma (Inst)